INVX 23/2/2567: CPAXT Outperform/ raise target price to Bt 39 from Bt 35 from higher synergy benefit (+1% of Sales) and margin improvement (Earnings upgrade by 2% in FY’25 and 5% in FY’26)

***Stocks of the day Prefer KTB and CPALL***Program Trading Buy STA BDMS SCB MTC vs Sell SCGP